Asking Price Contact for pricing
NOI Net Operating Income N/A
Cap Rate N/A
Asking Price Contact for pricing
NOI Net Operating Income N/A
Cap Rate N/A

Documents

Enter the "Deal room" for exclusive documents related to this property.

The Deal Room features confidential documents related to this property. To access the Deal Room, you will need to be logged in. If you don't have an account, please create one. More questions? Visit our FAQ.
I accept the confidentiality agreement
Create an account on the Investor Center to save your search and investment preferences, save and share opportunities, access exclusive documents, and more. More questions? Visit our FAQ. Approval for Deal Room access requires review by our Broker Team. You will be notified by email once your access is granted. More questions? Visit our FAQ. You'll need to sign a Confidentiality Agreement (CA) to access exclusive documents in the Deal Room. Signing the CA means you agree not to divulge or release sensitive information related to this property. More questions? Visit our FAQ.
I accept the confidentiality agreement I accept the confidentiality agreement
Create an account on the Investor Center to save your search and investment preferences, save and share opportunities, access exclusive documents, and more. More questions? Visit our FAQ. You'll need to sign a Confidentiality Agreement (CA) to access exclusive documents in the Deal Room. Signing the CA means you agree not to divulge or release sensitive information related to this property. More questions? Visit our FAQ.

Key Facts

Year Built 2008
Building Area
Land Area ()

Property Description

Jones Lang LaSalle (“JLL”), as exclusive representative, is pleased to offer for sale the fee-simple interest in 5225 Exploration Drive, a 54,173 SF Life Sciences facility (the “Asset” or “Property”) located in Indianapolis, IN. The Property is 82% occupied by 10 tenants with an average tenure at the property of 7.5 years. This property is being offered at a significant discount to replacement cost. The largest tenant who occupies half of the building, Q2 Solutions, has signed a LOI to expand, move to a net lease, and extend its lease for an additional five years starting in November 2021. The second largest tenant Novo Nordisk (NYSE: NVO and Moody’s A1) has extended its lease through November 2024. Both tenants have significant investments in their lab space and have increased their square footage through the extensions.



The Property offers investors the opportunity to acquire a Life Sciences facility that has strong tenure in its diverse roster of existing tenants, recent construction with limited to no deferred maintenance, and significant investment into the space from tenants. The property has typically been operated as a research incubator where companies have been able to capitalize on alignments with Purdue University. This has generally led to tenant friendly short-term leases and limited rental growth. An investor can renew, extend, and move the tenants into net leases to reduce landlord risk. This strategy has been started by Purdue Research Foundation by the renewal and expansion of Q2 Solutions. This facility remains crucial to Q2 Solutions as they have invested significant capital into building out multiple large lab spaces.

Investment Highlights

  • Desirable office / lab building branded as Purdue Technology Center currently 82% occupied by 10 tenants including national and start-up companies.


  • The two largest tenants, Novo Nordisk and Q2 Solutions, have signed longer lease commitments within the last 3 months adding certainty of income.


  •  Largest tenants have invested significant capital into their lab space. Novo Nordisk has invested over $2M into its space per Purdue Research Foundation (“PRF”).  Q2 has spent significant capital in its space as well likely in excess of $3M.


  •  Tenants have occupied this space for a weighted average of 7+ years showing the functionality and usefulness of the space.


  • The Property is located approximately 10 miles from IUPUI in downtown Indianapolis. IUPUI has medical research facilities on campus including the nation’s largest medical school, IU School of Medicine. 


  • IU Health and Eli Lilly are large medical and pharmaceutical presences in downtown Indianapolis as well which adds to the available talent pool for the property’s tenants.


  • Novartis, a Swiss multi-national pharmaceutical company, is building a $70M manufacturing facility on an adjacent property with average wages of $53 per hour which indicates continued industry interest in Indianapolis.
Last Updated Date: 03 Jun 2021
Nelson Almond
Nelson Almond
Associate, Capital Markets
Bruce Gordon
Bruce Gordon
Senior Vice President
Broker Licenses
RB14021777

There was an error submitting your request. Please try again, or submit you inquiry here.

 

PRIVACY NOTICE

Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.

Generally the personal information we collect from you are for the purposes of dealing with your enquiry.

We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.

+63282312281
Last Updated Date: 03 Jun 2021

Do you have any questions?  Visit our FAQ page

JLL  financing

JLL can help you finance and manage your portfolio.
Email us today to see how we can help achieve your ambitions.